Månsson, T. S., Askemyr, A., Sunnerhagen, T., Tham, J., Riesbeck, K., Mellhammar, L., . . . Lund University, F. o. M. (2025). Piperacillin/tazobactam versus carbapenems for 30-day mortality in patients with ESBL-producing Enterobacterales bloodstream infections: A retrospective, multicenter, non-inferiority, cohort study. Infection, 53(5), 1769-1777. https://doi.org/10.1007/s15010-025-02496-x
Chicago-Zitierstil (17. Ausg.)Månsson, Thomas Sahlström, et al. "Piperacillin/tazobactam Versus Carbapenems for 30-day Mortality in Patients with ESBL-producing Enterobacterales Bloodstream Infections: A Retrospective, Multicenter, Non-inferiority, Cohort Study." Infection 53, no. 5 (2025): 1769-1777. https://doi.org/10.1007/s15010-025-02496-x.
MLA-Zitierstil (9. Ausg.)Månsson, Thomas Sahlström, et al. "Piperacillin/tazobactam Versus Carbapenems for 30-day Mortality in Patients with ESBL-producing Enterobacterales Bloodstream Infections: A Retrospective, Multicenter, Non-inferiority, Cohort Study." Infection, vol. 53, no. 5, 2025, pp. 1769-1777, https://doi.org/10.1007/s15010-025-02496-x.